by Tri D. Do, MD, MPH
Article for Noodle Magazine
August 16, 2002
|
|
A is for Asian
Actually, A could just as easily stand for anyone. A glance at the
Centers for Disease Control (CDC) website on global hepatitis shows bright
red smears across Asia, the Pacific, South America, and Africa. The
triad of hepatitis A, B, and C are ubiquitous, and indeed, the diseases have
taken advantage of our need to be communal, sharing, and intimate.
To understand how these viruses affect various populations differently, we
need to take a look at how each is transmitted. Hepatitis A, for example,
is dependent on oral-fecal spread because the virus is only shed in the gut.
It’s much more prevalent in developing countries where up to 15% of people
get it every year, and so traveling to endemic areas puts you at greater
risk as well. Overwhelmingly, the spread of hep A is through personal
contact, which accounts for 25% of all cases in this country. ‘Personal
contact’ is the CDC’s polite euphemism for rimming and other things we love
to do that puts us in contact with feces. This is why most of the sporadic
epidemics of hep A that we see in this country are through food or sex, especially
among men who have sex with men (MSM) and people with multiple sex partners.
A lot of clinical information is useless so let’s indulge in a scenario.
You’re at a sex club and see a hot guy who you decide to go down on.
Unbeknownst to you, he had sex 15 minutes earlier with someone who carried
the virus, and he didn’t bother to clean himself afterwards. On the
other hand, personal contact can also just mean sharing cups or utensils
with someone who has hep A and didn’t wash his or her hands after going number
two. Voilà, oral-fecal contact.
Hepatitis C is transmitted through blood and can be spread by sharing needles
during injection drug use or by receiving contaminated blood transfusions.
It is therefore relatively less common in the gay community. There
is a substantial subset of injection drug users (IDU) among gay men as a
whole and also among guys who have sex with other men for subsistence.
In Asia, hep C is fairly common and in countries such as Viet Nam and the
Philippines, some estimates of hep C prevalence put it at nearly 100% among
IDUs. It’s also spread sexually, although gay men and Asian Pacific
Americans are no more likely to be infected than anyone else. The U.S.
has 40,000 new cases per year and 2.7 million people are chronically infected.
The spread of hepatitis B is much more interesting by comparison. About
one-third of the earth’s population has been exposed to it at some point.
It’s similar to HIV in its transmission and is spread through blood contact.
Many are chronic carriers of hep B and are therefore potent sources of new
infections. As a result, vertical transmission from mother to unborn
child occurs frequently. Close household contact may also pass the
virus on, probably from accidental vampirism—getting blood into one’s system
from an infected household member’s blood. Sharing toothbrushes or
razors might do the trick because unlike HIV, hep B is a rather hardy virus
that can survive the elements for long periods of time. Kissing does
not transmit the virus. The human race would have gone the way of the
dinosaur and feathered hair long ago if this were the case. Other modes
of infection include blood transfusion, sharing needles, and using contaminated
instruments in tattoo parlors, medical and dental clinics. The other
major vehicle for transmission is unsafe sexual contact with someone who
is infected. Oral sex is relatively safe and not known to transmit
hep B.
In Asia and the Pacific, hep B is considered endemic with 8-20% of the population
infected. We’re talking about 275 million of people, many of whom acquired
their infection in childhood. The prevalence is about 15% of all people
in China and Vietnam; 4% of those in Singapore, Taiwan, Tonga, and Samoa;
and 2% of Hawaiians are chronically infected. By comparison, 0.1% of Caucasian
Americans are infected.
How much of a problem is hep B for gay Asians and Pacific Islanders living
in the U.S.? No one really knows. However, poking around
a few departments of public health, including Seattle, New York, and San
Francisco, this was the best I could come up with: MSM constitute 32%
of new hep B infections in San Francisco and API make up 18% of chronic cases.
And still the question remains: what about those who are MSM and Asian?
Theoretically, we have a dual risk due to potential sexual as well as vertical
transmission before we are born. This has been confirmed in a recent
unpublished study of gay API men (GAM) in San Francisco’s clubs that showed
a whopping 28% were chronically infected with hep B. To quote a Chinese
friend of mine, “Ai-yah!” What proportion of this is due to vertical
transmission from our parents versus sexual partners is unclear. To
our credit, gay API-Americans are the most likely to talk about STDs and
HIV status before having sex, so it may be that vertical transmission is
mostly, but not entirely, to blame.
B is Because They Can Kill
Hepatitis A can be debilitating for a month or so. But for those who
rest and abstain from alcohol for six months, it goes away with nary a thought
or complication, and they get immunity, to boot. In contrast, hepatitis
C is more deadly than A. Between 75% and 85% of people who get a new
infection will go on to develop chronic disease. Up to 20% will develop
cirrhosis and 5% will die from chronic hep C.
So why all the hullabaloo about hep B, which just makes you a bit jaundiced,
nauseated, and fatigued? The acute infection in children and adults
can go relatively unnoticed, with 30% of people showing no outward signs.
However, one percent of people may die from the acute disease. Among
newborns that do get exposed at birth in endemic areas or who are born to
parents with the disease, 90% will develop chronic disease. Kids who
make it out of childbirth unscathed but are unfortunate enough to be exposed
up to the age of five are less likely to be chronic carriers, but 30-60%
of kids will still have chronic disease. And those who get it as adults
become chronic 6-10% of the time. People whose bodies are able to clear
the infection generally become immune. But for those who are chronically
infected, up to a quarter of them will die from liver failure or cancer,
the most serious complications of Hep B.
In the U.S. about 5,000 people die each year as a result of hep B.
One of the most devastating consequences of hep B is that it can lead to
liver cancer. In addition, hep B can also cause death through cirrhosis
and liver failure. Worldwide, hep B claims more than a million lives
each year. As the accompanying piece by Joel Engardio poignantly shows,
liver cancer tends to strike when people are young, between 30 and 65 years
of age. This is because the virus has had several decades to do its
damage to liver cells, transforming them into malignant lesions. Once
diagnosed, it’s often incurable because it advances silently at first and
only causes detectable problems when it’s too late. It’s insidious
and deadly, but can nothing be done about it? Early detection via blood
tests and ultrasonography has been proved to save lives. Clinicians
routinely screen those who are chronically infected. So once again,
this goes back to the issue of screening, because we first need to identify
those who are chronic carriers in order to prevent cancer in API adults.
For API men born abroad, the incidence of liver cancer in the U.S. is lower
than it is back in the motherland, but is much higher than it is for API
born here. Vietnamese have the highest risk at 13 times the rate of
Caucasian Americans. Filipinos, Japanese and Chinese men are three,
five and nine times more likely, respectively, to get liver cancer than their
white counterparts. Koreans are about on par with Chinese at eight
times the risk. For some API, we are more likely to die from liver
cancer than from lung cancer. As for gay API, no data exist whatsoever.
C is for Caring and Cure.
Unfortunately, no vaccine exists for hep C. A vaccine for hepatitis
B has been available since the early 1980s, but it’s not 100% effective.
As many as 15% of recipients who receive all three shots at 0, 1, and 6 months
acquire no immunity. They usually require additional booster shots
to get their immune systems primed. As vaccination is required for
health care professionals, I went for my vaccine in medical school and required
a total of six shots before antibodies developed. While this degree
of stubbornness is rare, it shows that testing for antibodies after vaccination
can be crucial. Currently, the CDC does not require routine antibody tests
after vaccination due to prohibitive costs, but your doctor will do it if
you ask.
National campaigns to vaccinate gay men against hep A & B have been underway
for years by organizations such as the Gay and Lesbian Medical Association
(GLMA) and local health departments. San Francisco started offering
vaccination at a gym in the Castro recently. As a board member of GLMA,
I was dismayed to find that only 22-32% of gay men polled at pride events
around the country had been vaccinated against hep B. We are currently
developing public policy to push for more active and targeted national vaccination
in the gay community and would like to see 100% coverage.
More drastically, in 1991 the CDC recommended vaccinating all newborns.
The vaccine has been 95% effective at stopping vertical transmission.
But even with widespread vaccination programs in the U.S., not everyone who’s
sexually active in 15 or 20 years will be immune to hep B in the future.
Immunity wanes. There is constant migration from endemic areas.
Access to health care can be prohibitive in this market-driven country, and
indeed, only 14-67% of API children in this country have actually received
all doses of the hep B vaccine.
When the CDC developed its statement on which populations are at risk and
should be screened or vaccinated, they egregiously failed to mention the
need to test Americans of API descent. Now, we’ll grant that these
recommendations were released 11 years ago, just before cultural awareness
became trendy, but even at that time, API’s made up three percent of the
population and half of all chronic cases of hep B. The recommendations
do make mention of the need to vaccinate adoptees from endemic areas
such as Asia. Since 1991, the CDC’s recommendations have expanded to
include infants born to immigrants from endemic areas but still fail to target
the actual source of new infections in infants: immigrants themselves.
It seems the world often forgets that children become adults, and when it
comes to disease prevention, adulthood is really when we begin to see the
horrific effects of long-term infection. Why hasn’t the U.S. implemented
a more aggressive strategy aimed at API’s in general? Sadly, even countries
in Asia and the Pacific have yet to implement widespread testing programs
in adults.
Some self-loathing types may wonder why the U.S. should even bother with
screening API’s on a large scale level at all. In total, Asian Pacific
Americans make up 11.3 million or 4.1% of the U.S. population, of whom 6.6
million or 58.4% are foreign-born. In short, there are a lot of people
who are carrying the virus and not getting tested or vaccinated. An
even more frightening prospect is that if Ward Connerly's drive to eliminate
the government’s collection of information race and ethnicity information
is successful, we’ll have no way to know whether or not trends among API’s
in liver cancer and hep B infection are improving in the future. One
study of Vietnamese adults in the bay area found that 48% had never even
heard of hep B. And while individual accountability and community efforts
are ideal, we’re all taxpayers and have a right to proper care. Our
government has the capacity to carry out such a targeted testing and vaccination
campaign. In the 1980s, programs implemented in Alaskan natives and
Native Americans have virtually wiped out the epidemic from their communities.
A safer, more globally-correct, and intuitive approach was undertaken by
the World Health Organization early on in 1991, when they called upon all
nations to vaccinate newborns and adolescents 11-18 years old. Whereas
8-15% of kids in many Asian countries were formerly found to be chronically
infected, that number is now reduced to 1% where vaccination programs have
been successfully implemented. Therefore demonstrating that good public
health intervention works. However, some low-income countries still cannot
afford to implement large-scale, country-wide vaccination programs.
Why the targeting of a specific age group when the reality is that so many
adults are also at risk? First, new disease in adults is less
likely to progress to liver failure or cancer than it is in kids. There
are also many logistical issues that policy makers and public health officials
need to address such as cost. Newborns are an easily accessible group,
being born in hospitals. The CDC also expanded its recommendations
in 1996 to include adolescents because they can prevent a kid from going
to school if they’re not vaccinated. For the parents, at least, this
is a strong motivation to get the shots.
So screening for hep B among all API’s regardless of age to figure out who’s
chronic makes perfect sense. But is it enough? The blood tests
used to discriminate between those with immunity due to past exposure and
those with chronic disease are not accurate. Among API’s in particular,
many people may harbor active disease without appearing to be chronically
infected. A full 2% of people with chronic liver disease have so-called
occult hep B, which has nothing to do with the supernatural and more to do
with the hidden nature of the infection. It can even progress to cirrhosis,
liver failure, and cancer. Looking for the DNA of virus itself can
spot occult cases, and perhaps this is something we should consider for those
who have been previously infected.
The real tragedy is that treatments like lamivudine and interferon exist
for hepatitis B that, in combination, are up to 50% effective at achieving
a cure. Some studies show that they may be somewhat less effective
in API, possibly due to the fact that chronic hep B may be more severe in
us. Presumably, treating and curing it will prevent progression to
cirrhosis and liver failure, as long as it’s caught early enough. Whether
or not these medications prevent progression to liver cancer in Hep B remains
to be seen, but there’s little reason to believe that they will not.
Similarly, for hepatitis C, interferon has been shown to stop progression
to cirrhosis. Unlike hep B, this treatment has been shown to prevent
liver cancer.
Now I generally regard myself as a pretty enlightened person, applying medical
developments to my own personal life and allowing private experience to inform
my public health work. But it only dawned on me while writing this
article to encourage testing to my boyfriend, who is of Japanese descent,
and to my family. And now that you know you have a one in four chance
of having hep B, wouldn’t it be worth it to find out for yourself?
I would strongly encourage you get yourself tested, and if you’re refused,
tell ‘em you’re savvier than that and they should know better. Better
yet, hit them with the facts and tell them that your life is worth the trouble.
|